Paper3294124
Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.
Galmiche JP and 9 others. Gut, 1988. Cited by 95 papers, by iCite.
Cite this record
ConductScience Library. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. Papers, record 3294124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3294124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Esophagitis, Peptic | Major topic |
| Piperidines | Major topic |
| Adult | |
| Aged | |
| Cisapride | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Combinations | |
| Esophagoscopy | |
| Female | |
| Heartburn | |
| Humans | |
| Male | |
| Middle Aged | |
| Random Allocation |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6311693 | Treatment of reflux oesophagitis with ranitidine. | Gut | 1983 | https://conductscience.org/library/papers/6311693 | PubMed |
| 2 | 6092288 | Ranitidine, cimetidine, antacids, and gastro-oesophageal reflux: results of a 20-hour oesophageal pH study. | Int J Clin Pharmacol Res | 1984 | https://conductscience.org/library/papers/6092288 | PubMed |
| 3 | 3884468 | Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). | Gut | 1985 | https://conductscience.org/library/papers/3884468 | PubMed |
| 4 | 2866742 | Medical therapy for reflux esophagitis: 1986 and beyond. | Ann Intern Med | 1986 | https://conductscience.org/library/papers/2866742 | PubMed |
| 5 | 3940501 | Treatment of severe reflux esophagitis with cimetidine and metoclopramide. | Ann Intern Med | 1986 | https://conductscience.org/library/papers/3940501 | PubMed |
| 6 | 3518407 | Chronic oral treatment with cisapride decreases high bile salt reflux rates. | Am J Gastroenterol | 1986 | https://conductscience.org/library/papers/3518407 | PubMed |
| 7 | 6407606 | Cimetidine and metoclopramide in oesophageal reflux disease. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6407606 | PubMed |
| 8 | 13747 | Patterns of gastroesophageal reflux in health and disease. | Ann Surg | 1976 | https://conductscience.org/library/papers/13747 | PubMed |
| 9 | 340333 | Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. | Gastroenterology | 1978 | https://conductscience.org/library/papers/340333 | PubMed |
| 10 | 346430 | Oral cimetidine in reflux esophagitis: a double blind controlled trial. | Gastroenterology | 1978 | https://conductscience.org/library/papers/346430 | PubMed |
| 11 | 7000475 | Controlled trial of cimetidine in reflux esophagitis. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/7000475 | PubMed |
| 12 | 7004292 | Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings. | Ann Intern Med | 1980 | https://conductscience.org/library/papers/7004292 | PubMed |
| 13 | 7016659 | Pathogenesis of reflux esophagitis. | Gastroenterology | 1981 | https://conductscience.org/library/papers/7016659 | PubMed |
| 14 | 319356 | A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. | N Engl J Med | 1977 | https://conductscience.org/library/papers/319356 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29606884 | Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions. | Clin Exp Gastroenterol | 2018 | https://conductscience.org/library/papers/29606884 | PubMed |
| 27075264 | Management of refractory typical GERD symptoms. | Nat Rev Gastroenterol Hepatol | 2016 | https://conductscience.org/library/papers/27075264 | PubMed |
| 22523727 | Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux. | J Neurogastroenterol Motil | 2012 | https://conductscience.org/library/papers/22523727 | PubMed |
| 21673949 | Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials. | Open Med | 2007 | https://conductscience.org/library/papers/21673949 | PubMed |
| 18370513 | Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups. | Clin Drug Investig | 1998 | https://conductscience.org/library/papers/18370513 | PubMed |
| 16015691 | Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/16015691 | PubMed |
| 15345875 | Management of unresponsive asthma. | Indian J Pediatr | 2004 | https://conductscience.org/library/papers/15345875 | PubMed |
| 15082617 | A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials. | Gut | 2004 | https://conductscience.org/library/papers/15082617 | PubMed |
| 12749748 | Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly. | Drugs Aging | 2003 | https://conductscience.org/library/papers/12749748 | PubMed |
| 11096564 | Noncardiac Chest Pain of Esophageal Origin. | Curr Treat Options Gastroenterol | 1998 | https://conductscience.org/library/papers/11096564 | PubMed |
| 10870511 | An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. | CMAJ | 2000 | https://conductscience.org/library/papers/10870511 | PubMed |
| 10741335 | An evidence-based appraisal of reflux disease management--the Genval Workshop Report. | Gut | 1999 | https://conductscience.org/library/papers/10741335 | PubMed |
| 10724795 | Economic evaluation of long-term management strategies for erosive oesophagitis. | Pharmacoeconomics | 1999 | https://conductscience.org/library/papers/10724795 | PubMed |
| 8879971 | Cisapride. Drug interactions of clinical significance. | Drug Saf | 1996 | https://conductscience.org/library/papers/8879971 | PubMed |
| 8527013 | A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders. | Drug Saf | 1995 | https://conductscience.org/library/papers/8527013 | PubMed |
| 7601011 | Pharmacological management of gastro-oesophageal reflux disease. | Drugs | 1995 | https://conductscience.org/library/papers/7601011 | PubMed |
| 7510617 | Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. | Drugs | 1994 | https://conductscience.org/library/papers/7510617 | PubMed |
| 3065057 | Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. | Drugs | 1988 | https://conductscience.org/library/papers/3065057 | PubMed |
| 2680794 | Effect of cisapride on postprandial gastro-oesophageal reflux. | Gut | 1989 | https://conductscience.org/library/papers/2680794 | PubMed |
| 2573565 | Histamine-2-receptor antagonists in gastro-oesophageal reflux. | Gut | 1989 | https://conductscience.org/library/papers/2573565 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3294124
GET https://conductscience.org/api/papers/v1/3294124/cited_by?page=2